Soleno Therapeutics (SLNO) Work In Process (2025 - 2026)
Soleno Therapeutics (SLNO) posted quarterly Work In Process of $5.6 million for Q1 2026, up 105.39% quarter-over-quarter from $2.7 million in Q4 2025.
Soleno Therapeutics (SLNO) Work In Process (2025 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has reported Work In Process for 2 consecutive years, with $5.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Work In Process changed N/A year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $5.6 million (changed N/A YoY), while the FY2025 annual figure was $2.7 million, changed N/A from the prior year.
- Work In Process climbed to $5.6 million in Q1 2026 per SLNO's latest filing, from $2.7 million in the prior quarter.
- Across five years, Work In Process topped out at $5.6 million in Q1 2026 and bottomed at $950000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.57 Mn |
| Dec 31, 2025 | 2.71 Mn |
| Sep 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 950,000.00 |